Skip to main content
. 2016 May 25;21(6):671–675. doi: 10.1634/theoncologist.2015-0470

Figure 2.

Figure 2.

Progression-free survival (PFS) stratified by nonpancreatic versus pancreatic neuroendocrine tumors (NETs). Median PFS was 12 and 13 months for nonpancreatic NETs and pancreatic NETs, respectively.

Abbreviations: NS, not significant; pNET, pancreatic neuroendocrine tumor.